What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
His primary areas of investigation include Cell biology, Keratin, Intermediate filament, Keratin 8 and Phosphorylation.
The concepts of his Cell biology study are interwoven with issues in Mallory body, Biochemistry, Mutant and Pathogenesis.
His Keratin study combines topics from a wide range of disciplines, such as Molecular biology, Type II keratin, Keratin Filament and Keratin 7.
The Molecular biology study which covers Apoptosis that intersects with YAP1.
His Intermediate filament research includes elements of Neurofilament, Actin and Cytoplasm.
His research investigates the connection between Keratin 8 and topics such as Mitosis that intersect with problems in Epitope.
His most cited work include:
- ‘Hard’ and ‘soft’ principles defining the structure, function and regulation of keratin intermediate filaments (528 citations)
- New consensus nomenclature for mammalian keratins (527 citations)
- The pancreatic stellate cell: a star on the rise in pancreatic diseases. (468 citations)
What are the main themes of his work throughout his whole career to date?
M. Bishr Omary mainly investigates Keratin, Cell biology, Intermediate filament, Molecular biology and Keratin 8.
He combines subjects such as Genetically modified mouse, Biochemistry, Phosphorylation and Keratin Filament with his study of Keratin.
His Cell biology research includes themes of Lamin and Mallory body.
His work deals with themes such as Neurofilament, Protein filament and Pancreas, which intersect with Intermediate filament.
His Molecular biology study also includes fields such as
- Hepatocyte and related Oxidative stress,
- Liver injury that connect with fields like Acetaminophen.
His Keratin 8 research is multidisciplinary, relying on both Liver disease, Endocrinology and Keratin 5.
He most often published in these fields:
- Keratin (45.42%)
- Cell biology (42.86%)
- Intermediate filament (32.23%)
What were the highlights of his more recent work (between 2014-2021)?
- Cell biology (42.86%)
- Liver injury (15.75%)
- Lamin (9.16%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cell biology, Liver injury, Lamin, Keratin and Internal medicine.
His Cell biology research incorporates elements of Intermediate filament and Steatohepatitis.
M. Bishr Omary has researched Liver injury in several fields, including Cirrhosis and Acetaminophen, Biochemistry.
The study incorporates disciplines such as Nuclear lamina and Phosphorylation in addition to Lamin.
His work carried out in the field of Keratin brings together such families of science as Vimentin, Molecular biology and Cell.
His Internal medicine study incorporates themes from Gastroenterology and Endocrinology.
Between 2014 and 2021, his most popular works were:
- Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1 (112 citations)
- Types I and II Keratin Intermediate Filaments (59 citations)
- Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity (52 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
M. Bishr Omary mostly deals with Cell biology, Lamin, Keratin, Intermediate filament and Nuclear lamina.
His Cell biology research incorporates themes from Erythropoietic protoporphyria, Protoporphyrin and LMNA.
His biological study spans a wide range of topics, including Molecular biology and Cytoplasm.
His Molecular biology study combines topics in areas such as Chronic liver disease, Biochemistry and Pathology.
His Intermediate filament study integrates concerns from other disciplines, such as Mutation, Proteomics, SUMO protein and Phosphorylation.
His work in Keratin 8 covers topics such as Liver injury which are related to areas like Hepatocyte, Autophagy and Wnt signaling pathway.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
